Legal & General Group
HLVX

Legal & General Group’s HilleVax HLVX Stock Holding History

Legal & General Group’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,884
Closed -$4.18K – 3466
2025
Q1 		$4.18K Hold
2,884
– – ﹤0.01% 3303
2024
Q4 		$6.01K Hold
2,884
– – ﹤0.01% 3327
2024
Q3 		$5.09K Sell
2,884
-18,341
-86% -$47K ﹤0.01% 3365
2024
Q2 		$307K Buy
21,225
+3,997
+23% +$54.9K ﹤0.01% 2595
2024
Q1 		$287K Buy
17,228
+6,901
+67% +$110K ﹤0.01% 2615
2023
Q4 		$166K Buy
10,327
+416
+4% +$5.53K ﹤0.01% 2723
2023
Q3 		$133K Sell
9,911
-250
-2% -$3.52K ﹤0.01% 2795
2023
Q2 		$175K Buy
10,161
+5,047
+99% +$78.2K ﹤0.01% 2760
2023
Q1 		$84.5K Buy
5,114
+297
+6% +$4.75K ﹤0.01% 2803
2022
Q4 		$80.6K Buy
4,817
+3,466
+257% +$62.6K ﹤0.01% 2862
2022
Q3 		$23K Buy
+1,351
New +$19.6K ﹤0.01% 3171

Other funds holding HLVX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
LMC
Lightspeed Management Company Menlo Park, California $988M AUM 7.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Legal & General Group's HLVX Position: Q2 2025 in Review

Legal & General Group sold out of HilleVax (HLVX) in Q2 2025, closing a stake of 2,884 shares — an estimated $4.18K sold.

Legal & General Group first reported a position in HLVX in Q3 2022 and held it in 11 quarters. The position peaked at $307K in Q2 2024. 74 funds tracked by Wall St. Rank hold HLVX as of Q2 2025.

  • Legal & General Group reported no remaining HilleVax position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 2,884 HilleVax shares in Q2 2025, an estimated $4.18K.
  • Legal & General Group first reported a position in HilleVax in Q3 2022 and held it in 11 quarters.
  • Legal & General Group's HilleVax position peaked at $307K in Q2 2024.
  • 74 funds tracked by Wall St. Rank held HilleVax as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.